Due to the high peroxidase-like activity and small lateral size of graphene quantum dots (GQDs), the covalently assembled GQDs/Au electrode exhibits great performance and stability in H(2)O(2) detection. It is better or comparable to some enzyme-immobilized electrodes, and thus could be useful in sensing H(2)O(2) changes in biological systems.

Graphene quantum dots (GQDs), owing to their unique morphology, ultra-small lateral sizes, and exceptional properties, hold great promise for many applications, especially in the biomedical field. In this work, the cellular internalization, distribution, and cytotoxicity of the GQDs are explored complementarily using transmission electron microscopy, confocal laser scanning microscopy, UV-vis, and fluorescence spectroscopies, and flow cytometry with human gastric cancer MGC-803 and breast cancer MCF-7 cells. It is demonstrated that the GQDs are internalized primarily through caveolae-mediated endocytosis. The effects of GQDs on the cell viability, internal cellular reactive oxygen species (ROS) level, mitochondrial membranes potential, and cell cycles show that the cytotoxicity of GQDs is lower than that of the micrometer-sized graphene oxide (GO). The low cytotoxicity and size consistence render GQDs appropriate for biomedical application.

Graphene quantum dots (GQDs) maintain the intrinsic layered structural motif of graphene but with smaller lateral size and abundant periphery carboxylic groups, and are more compatible with biological system, thus are promising nanomaterials for therapeutic applications. Here we show that GQDs have a superb ability in drug delivery and anti-cancer activity boost without any pre-modification due to their unique structural properties. They could efficiently deliver doxorubicin (DOX) to the nucleus through DOX/GQD conjugates, because the conjugates assume different cellular and nuclear internalization pathways comparing to free DOX. Also, the conjugates could enhance DNA cleavage activity of DOX markedly. This enhancement combining with efficient nuclear delivery improved cytotoxicity of DOX dramatically. Furthermore, the DOX/GQD conjugates could also increase the nuclear uptake and cytotoxicity of DOX to drug-resistant cancer cells indicating that the conjugates may be capable to increase chemotherapy efficacy of anti-cancer drugs that are suboptimal due to the drug resistance.

No abstract

This review selectively describes the recent progress in the interactions of proteins (enzymes) and shortchain peptides with graphene and graphene oxide (GO). Particularly, the advances of the immobilization mechanisms of enzymes on graphene and GO, the catalytic properties of the immobilized enzymes, and their applications are summarized in detail. The interfacings of the peptides with graphene and GO, the as assembled conjugates, and their potential applications are discussed briefly. The possible ongoing development for the assembly of conjugates of graphene and GO with proteins and peptides in a controlled manner is speculated upon.